🇺🇸 FDA
Patent

US 8629177

Nanoencapsulated delta-9-tetrahydrocannabinol

granted A61KA61K31/352A61K31/658

Quick answer

US patent 8629177 (Nanoencapsulated delta-9-tetrahydrocannabinol) held by Aphios Corporation expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aphios Corporation
Grant date
Tue Jan 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/352, A61K31/658, A61K9/4858, A61K9/5153